+ content: "We are thrilled to announce that Breakthrough T1D and the Helmsley Charitable Trust have awarded a $3.9 million grant to the Forlenza–Shakeri project, a multi-center initiative co-led by Dr. Shakeri as Contact PI alongside Dr. Greg Forlenza (CU Anschutz). UVA will lead algorithm development and engineering work packages, operating alongside clinical sites at UVA, CU (Barbara Davis Center), and UCSF to advance next-generation automated insulin delivery systems. The initiative is bolstered by $800,000 in in-kind contributions from Tandem Diabetes Care and Arecor, bringing total support to nearly $4.7 million."
0 commit comments